TUBEROUS SCLEROSIS COMPLEX
Clinical trials for TUBEROUS SCLEROSIS COMPLEX explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
TSC patients continue seizure drug in Long-Term safety check
Disease control OngoingThis study looks at the long-term safety of the drug everolimus in people with tuberous sclerosis complex (TSC) who have hard-to-control seizures. Participants had already been taking everolimus in an earlier study and were still benefiting from it. The main goal is to track side…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New drug radiprodil aims to tame seizures in rare brain disorders
Symptom relief OngoingThis study tests an experimental drug called radiprodil in 30 people with tuberous sclerosis complex (TSC) or focal cortical dysplasia (FCD) type II who have not responded to at least two seizure medications. The goal is to see if the drug is safe and can reduce seizures and beha…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE1, PHASE2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:26 UTC
-
Epidiolex liver check: study tracks long-term injury risk
Knowledge-focused OngoingThis study checks if long-term use of Epidiolex (cannabidiol) can cause liver damage or scarring in people with certain seizure disorders. It includes 154 participants who already take or will start Epidiolex for Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis com…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC
-
New PET scan may reveal early drug effects in rare lung disease
Knowledge-focused OngoingThis small study tests whether a special PET scan using [11C]acetate can detect early signs that the drug rapamycin is working in people with lymphangioleiomyomatosis (LAM), a rare lung disease. Seven adults with LAM and kidney growths will get one or two scans over 3-6 months. T…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 19, 2026 11:49 UTC